|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-2-25
|
|
pubmed:abstractText |
The heterogeneity of stage II colon cancer underlines the need for identifying high-risk, lymph node-negative patients. The objective of this study was to define a multimarker prognostic model of 5-year survival in patients with lymph node-negative, mismatch repair (MMR)-proficient colorectal cancer (CRC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD8,
http://linkedlifedata.com/resource/pubmed/chemical/PLAUR protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Proliferating Cell Nuclear Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Urokinase Plasminogen...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator,
http://linkedlifedata.com/resource/pubmed/chemical/p27 antigen
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
495-502
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18076013-Antigens, CD8,
pubmed-meshheading:18076013-Colorectal Neoplasms,
pubmed-meshheading:18076013-Humans,
pubmed-meshheading:18076013-Kaplan-Meier Estimate,
pubmed-meshheading:18076013-Lymphatic Metastasis,
pubmed-meshheading:18076013-Microarray Analysis,
pubmed-meshheading:18076013-Multivariate Analysis,
pubmed-meshheading:18076013-Neoplasm Staging,
pubmed-meshheading:18076013-Phenotype,
pubmed-meshheading:18076013-Predictive Value of Tests,
pubmed-meshheading:18076013-Prognosis,
pubmed-meshheading:18076013-Proliferating Cell Nuclear Antigen,
pubmed-meshheading:18076013-Proportional Hazards Models,
pubmed-meshheading:18076013-Receptors, Cell Surface,
pubmed-meshheading:18076013-Receptors, Urokinase Plasminogen Activator,
pubmed-meshheading:18076013-T-Lymphocytes,
pubmed-meshheading:18076013-Tumor Markers, Biological,
pubmed-meshheading:18076013-Urokinase-Type Plasminogen Activator
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
|
|
pubmed:affiliation |
Institute of Pathology, University Hospital of Basel, Basel, Switzerland. izlobec@uhbs.ch
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
